Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.
暂无分享,去创建一个
Yasunari Kanda | Takeshi Kunihiro | Junko Kurokawa | Tetsushi Furukawa | T. Furukawa | J. Kurokawa | Y. Kanda | Eriko Matsui | Tomohiro Hayakawa | Tomoko Ando | Seiji Kobayashi | Hiroaki Yada | T. Ando | Seiji Kobayashi | T. Kunihiro | Tomohiro Hayakawa | E. Matsui | Hiroaki Yada
[1] S. Miyagawa,et al. Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy , 2013, BioMed research international.
[2] Gary R. Mirams,et al. Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. , 2012, Journal of molecular and cellular cardiology.
[3] N. Kohmura,et al. A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.
[4] Divya Rajamohan,et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.
[5] S. Harding,et al. Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. , 1988, Journal of molecular and cellular cardiology.
[6] 田中 智文,et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes , 2012 .
[7] Takeshi Kunihiro,et al. Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis. , 2012, Tissue engineering. Part C, Methods.
[8] G. Dreissen,et al. The constant beat: cardiomyocytes adapt their forces by equal contraction upon environmental stiffening , 2013, Biology Open.
[9] D. Kass,et al. Mechanisms of diastolic dysfunction in heart failure. , 2006, Trends in cardiovascular medicine.
[10] Peter Blomgren,et al. Image Processing Techniques for Assessing Contractility in Isolated Neonatal Cardiac Myocytes , 2011, Int. J. Biomed. Imaging.
[11] James A Thomson,et al. Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes: Action Potential Characterization , 2003, Circulation research.
[12] Milica Radisic,et al. Influence of substrate stiffness on the phenotype of heart cells , 2010, Biotechnology and bioengineering.
[13] Sean P. Palecek,et al. Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells , 2012, International journal of cell biology.
[14] Mohammed Ghanbari,et al. The Cross-Search Algorithm for Motion Estimation , 1990 .
[15] Jackie Schiller,et al. Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes , 2011, PloS one.
[16] Sean P. Palecek,et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.
[17] W. Bloch,et al. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. , 2012, Stem cells and development.
[18] R Towart,et al. The Electro‐Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias , 2010, British journal of pharmacology.
[19] T. Tameyasu,et al. Nonsteady motion in unloaded contractions of single frog cardiac cells. , 1985, Biophysical journal.
[20] K. Yasuda,et al. On-chip constructive cell-network study (II): on-chip quasi-in vivo cardiac toxicity assay for ventricular tachycardia/fibrillation measurement using ring-shaped closed circuit microelectrode with lined-up cardiomyocyte cell network , 2011, Journal of nanobiotechnology.
[21] T. Shinozawa,et al. Determination of Appropriate Stage of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes for Drug Screening and Pharmacological Evaluation In Vitro , 2012, Journal of biomolecular screening.
[22] D. Bers,et al. Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays − Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell , 2013 .
[23] OrenCaspi,et al. Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells , 2007 .
[24] P. Guns,et al. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. , 2012, Journal of pharmacological and toxicological methods.
[25] K. Spitzer,et al. A video system for measuring motion in contracting heart cells , 1988, IEEE Transactions on Biomedical Engineering.
[26] M. Honkanen,et al. Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation , 2014, Biomedical engineering online.
[27] Marius Wernig,et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Shinya Yamanaka,et al. iPS cells: a source of cardiac regeneration. , 2011, Journal of molecular and cellular cardiology.
[29] M. Periasamy,et al. Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. , 2007, Cardiovascular research.
[30] Lior Gepstein,et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.
[31] J. Schiller,et al. Calcium Handling in Embryonic Stem Cell–Derived Cardiac Myocytes , 2006, Annals of the New York Academy of Sciences.
[32] James A Thomson,et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.
[33] J. Schiller,et al. Calcium Handling in Human Embryonic Stem Cell‐Derived Cardiomyocytes , 2008, Stem cells.
[34] Liang Guo,et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[35] S. Goldman,et al. Treatment of verapamil toxicity in intact dogs. , 1986, The Journal of clinical investigation.
[36] Michael Xavier Doss,et al. Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on IKr , 2012, PloS one.
[37] H. Guillou,et al. Spatial organization of the extracellular matrix regulates cell–cell junction positioning , 2012, Proceedings of the National Academy of Sciences.
[38] H. Wellens,et al. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. , 1977, British heart journal.
[39] Kevin D. Costa,et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] Euan A. Ashley,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[41] G. Langer,et al. Correlation of the Glycoside Response− the Force Staircase− and the Action Potential Configuration in the Neonatal Rat Heart , 1975, Circulation research.
[42] P. Doevendans,et al. The human adult cardiomyocyte phenotype. , 2003, Cardiovascular research.
[43] M. Bönstrup,et al. Development of a Drug Screening Platform Based on Engineered Heart Tissue , 2010, Circulation research.
[44] Ulrich Egert,et al. Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Estimation of Action Potential Changes from Field Potential Recordings in Multicellular Mouse Cardiac Myocyte Cultures Key Words Microelectrode Array @bullet Action Potential Upstroke @bullet Action P , 2022 .
[45] Ivan Rusyn,et al. Multiparameter In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using iPSC Cells , 2013, Journal of biomolecular screening.
[46] M. GHANBARI,et al. The cross-search algorithm for motion estimation [image coding] , 1990, IEEE Trans. Commun..
[47] K. Sawada,et al. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes. , 2014, Journal of pharmacological and toxicological methods.
[48] Hung-Fat Tse,et al. Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2011, Stem Cell Reviews and Reports.
[49] Peter Blomgren,et al. Image Processing Techniques for Assessing Contractility in Isolated Adult Cardiac Myocytes , 2010, Int. J. Biomed. Imaging.
[50] J. Valentin,et al. Validation of an in vitro contractility assay using canine ventricular myocytes. , 2012, Toxicology and applied pharmacology.
[51] Tatsuya Shimizu,et al. Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart , 2013 .
[52] Masato Saito,et al. Non-invasive characterization of mouse embryonic stem cell derived cardiomyocytes based on the intensity variation in digital beating video. , 2010, The Analyst.
[53] Jeen-Shang Lin,et al. Cell traction force and measurement methods , 2007, Biomechanics and modeling in mechanobiology.
[54] U. Egert,et al. Heart on a Chip — Extracellular Multielectrode Recordings from Cardiac Myocytes in Vitro , 2005 .
[55] A. C. Pessina,et al. Comparison between isomyosin pattern and contractility of right ventricular myocytes isolated from rats with right cardiac hypertrophy , 1989, Basic Research in Cardiology.
[56] Manish J. Butte,et al. Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes , 2012, PloS one.
[57] K W Hewett,et al. Cell and sarcomere contractile performance from the same cardiocyte using video microscopy. , 1993, Journal of applied physiology.
[58] Thomas Rau,et al. Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology , 2011, PloS one.
[59] Clare M Waterman,et al. High resolution traction force microscopy based on experimental and computational advances. , 2008, Biophysical journal.
[60] J. Ohayon,et al. Quantification of cardiomyocyte contraction based on image correlation analysis , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[61] Ben Fabry,et al. Traction fields, moments, and strain energy that cells exert on their surroundings. , 2002, American journal of physiology. Cell physiology.
[62] Tomoaki Inoue,et al. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. , 2011, Journal of pharmacological sciences.
[63] M. Dembo,et al. Stresses at the cell-to-substrate interface during locomotion of fibroblasts. , 1999, Biophysical journal.
[64] Karl-Heinz Boven,et al. Micro-Electrode Arrays in Cardiac Safety Pharmacology , 2004, Drug safety.
[65] Charles E. Murry,et al. Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.
[66] P. Guns,et al. The electro‐mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk , 2012, British journal of pharmacology.
[67] Lior Gepstein,et al. Human embryonic stem cells for cardiomyogenesis. , 2008, Journal of molecular and cellular cardiology.
[68] S. Houser,et al. Mechanical properties of adult feline ventricular myocytes in culture. , 1991, The American journal of physiology.
[69] W. Shim,et al. Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells , 2012, PloS one.
[70] Ulrich Egert,et al. Effect of Cardioactive Drugs on Action Potential Generation and Propagation in Embryonic Stem Cell-Derived Cardiomyocytes , 2007, Cellular Physiology and Biochemistry.
[71] S. Bremer,et al. Digital movie analysis for quantification of beating frequencies, chronotropic effects, and beating areas in cardiomyocyte cultures. , 2008, Assay and drug development technologies.
[72] Ming Tang,et al. Human and Murine Embryonic Stem Cell-Derived Cardiomyocytes Serve Together as a Valuable Model for Drug Safety Screening , 2010, Cellular Physiology and Biochemistry.
[73] Teruo Okano,et al. Cell sheet transplantation for heart tissue repair. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[74] Yasunari Kanda,et al. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study. , 2014, Journal of pharmacological sciences.
[75] S. Harding,et al. β1‐ and β2‐adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non‐failing adult human heart , 2008, British journal of pharmacology.
[76] Robert Passier,et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.
[77] LimorZwi,et al. Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009 .
[78] N. Nakatsuji,et al. Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. , 2013, European heart journal.
[79] Kam W Leong,et al. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. , 2011, Biomaterials.